MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 198 filers reported holding MEDICINES CO in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,674,000 | +332.4% | 233,480 | +141.7% | 0.01% | +100.0% |
| Q1 2019 | $2,700,000 | +116.7% | 96,600 | +48.4% | 0.01% | +100.0% |
| Q4 2018 | $1,246,000 | -17.8% | 65,100 | +28.4% | 0.00% | 0.0% |
| Q3 2018 | $1,516,000 | -22.3% | 50,700 | -4.7% | 0.00% | -40.0% |
| Q2 2018 | $1,952,000 | -39.3% | 53,200 | -45.5% | 0.01% | -37.5% |
| Q1 2018 | $3,215,000 | -79.7% | 97,600 | -77.1% | 0.01% | -82.2% |
| Q3 2017 | $15,819,000 | +134.0% | 427,067 | +61.8% | 0.04% | +60.7% |
| Q1 2015 | $6,759,000 | +191.5% | 263,900 | +214.9% | 0.03% | +180.0% |
| Q4 2014 | $2,319,000 | +29.6% | 83,800 | +4.5% | 0.01% | +11.1% |
| Q3 2014 | $1,790,000 | -52.7% | 80,200 | -38.4% | 0.01% | -50.0% |
| Q2 2014 | $3,781,000 | +33.6% | 130,100 | +30.6% | 0.02% | +28.6% |
| Q1 2014 | $2,831,000 | -28.7% | 99,600 | -3.1% | 0.01% | -30.0% |
| Q4 2013 | $3,970,000 | -14.2% | 102,800 | -25.6% | 0.02% | -23.1% |
| Q3 2013 | $4,629,000 | -23.7% | 138,100 | -30.0% | 0.03% | -25.7% |
| Q2 2013 | $6,069,000 | – | 197,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |